Purinergic modulation of neuronal activity in the mesolimbic dopaminergic system in vivo

Synapse

Volumn 47, Issue 2, 2003, Pages 134-142

  Krugel, Ute ^a   Kittner, Holger ^a   Franke, Heike ^a   Illes, Peter ^a  

^a UNIVERSITY OF LEIPZIG   (Germany)

Author keywords

Dopamine; EEG; Nucleus accumbens; P1 receptors; P2 receptors; Ventral tegmental area

Indexed keywords

2 METHYLTHIOADENOSINE TRIPHOSPHATE; ADENOSINE; ADENOSINE RECEPTOR; DOPAMINE; MEMBRANE RECEPTOR; PURINE P2 RECEPTOR; PURINE RECEPTOR; PYRIDOXAL PHOSPHATE 6 AZOPHENYL 2',4' DISULFONIC ACID;

ALPHA RHYTHM; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BEHAVIOR; BETA RHYTHM; CONTROLLED STUDY; DOPAMINE RELEASE; DOPAMINERGIC SYSTEM; ELECTROENCEPHALOGRAM; FEEDBACK SYSTEM; LIMBIC SYSTEM; MALE; MICRODIALYSIS; NERVE CONDUCTION; NONHUMAN; NUCLEUS ACCUMBENS; PRIORITY JOURNAL; RAT; VENTRAL TEGMENTUM;

ADENOSINE; ADENOSINE TRIPHOSPHATE; ANIMALS; DOPAMINE; ELECTROENCEPHALOGRAPHY; MALE; MICRODIALYSIS; NEURONS; NUCLEUS ACCUMBENS; PURINES; PYRIDOXAL PHOSPHATE; RATS; RATS, WISTAR; RECEPTORS, PURINERGIC P1; RECEPTORS, PURINERGIC P2; THEOPHYLLINE; THIONUCLEOTIDES; VENTRAL TEGMENTAL AREA;

EID: 0037291563     PISSN: 08874476     EISSN: None     Source Type: Journal    
DOI: 10.1002/syn.10162     Document Type: Article

References (61)

1. Alexander SP, Reddington M. 1989. The cellular localization of adenosine receptors in rat neostriatum. Neuroscience 28:645-651.
2. 1 receptor agonist, on spontaneous and evoked dopamine release in rat neostriatum. Neurosci Lett 185:29-32.
3. 12, an important drug target in platelets. Trends Pharmacol Sci 22:388-391.
4. Bauer G. EEG, drug effects, and central nervous system poisoning. In: Niedermeyer E, Lopes da Silva F, editors. Electroencephalography. Baltimore, Munich: Urban & Schwarzenberg. p 567-578.
5. Burnstock G. 1986. Purines and cotransmitters in adrenergic and cholinergic neurones. Prog Brain Res 68:193-203.
6. Casas M, Prat G, Robledo P, Barbanoj M, Kulisevsky J, Jane F. 2000. Methylxanthines reverse the adipsic and aphagic syndrome induced by bilateral 6-hydroxydopamine lesions of the nigrostriatal pathway in rats. Pharmacol Biochem Behav 66:257-263.
7. 2A receptor stimulation on GABA release from the striatum of young and aged rats in vivo. Neuroreport 10:3933-3937.
8. +-evoked glutamate release in vivo in young and aged rats. Neuroreport 10:687-691.
9. Craig CG, White TD. 1992. Low-level N-methyl-D-aspartate receptor activation provides a purinergic inhibitory threshold against further N-methyl-D-aspartate-mediated neurotransmission in the cortex. J Pharmacol Exp Ther 260:1278-1284.
10. Craig CG, White TD. 1993. N-methyl-D-aspartate- and non-N-methyl-D-aspartate-evoked adenosine release from rat cortical slices: Distinct purinergic sources and mechanisms of release. J Neurochem 60:1073-1080.
11. Cunha RA. 2001. Adenosine as a neuromodulator and as a homeostatic regulator in the nervous system: Different roles, different sources and different receptors. Neurochem Int 38:107-125.
12. Dunwiddie TV, Diao L, Proctor WR. 1997. Adenine nucleotides undergo rapid, quantitative conversion to adenosine in the extracellular space in rat hippocampus. J Neurosci 17:7673-7682.
13. Edwards FA. 1996. Features of P2X receptor-mediated synapses in the rat brain: Why doesn't ATP kill the postsynaptic cell? Ciba Found Symp 198:278-286.
14. Entholzer E, Mielke L, Pichlmeier R, Weber F, Schneck H. 1995. EEG changes during sedation with gamma-hydroxybutyric acid. Anaesthesist 44:345-350.
15. Ferger B, Kropf W, Kuschinsky K. 1994. Studies on electroencephalogram (EEG) in rats suggest that moderate doses of cocaine or d-amphetamine activate D1 rather than D2 receptors. Psychopharmacology (Berl) 114:297-308.
16. Ferre S. 1997. Adenosine-dopamine interactions in the ventral striatum. Implications for the treatment of schizophrenia. Psychopharmacology (Berl) 133:107-120.
17. Fredholm BB, Dunwiddie TV. 1988. How does adenosine inhibit transmitter release? Trends Pharmacol Sci 9:130-134.
18. Fredholm BB, Abbracchio MP, Burnstock G, Daly JW, Harden TK, Jacobson KA, Leff P, Williams M. 1994. Nomenclature and classification of purinoceptors. Pharmacol Rev 46:143-156.
19. Gereau RW, Conn PJ. 1994. Potentiation of cAMP responses by metabotropic glutamate receptors depresses excitatory synaptic transmission by a kinase-independent mechanism. Neuron 12:1121-1129.
20. 2A receptors in the nucleus accumbens and the caudate-putamen. Eur J Pharmacol 323:127-131.
21. Hollopeter G, Jantzen HM, Vincent D, Li G, England L, Ramakrishnan V, Yang RB, Nurden P, Nurden A, Julius D, Conley PB. 2001. Identification of the platelet ADP receptor targeted by antithrombotic drugs. Nature 409:202-207.
22. Hoyle CHV, Burnstock G. 1991. ATP receptors and their physiological roles. In: Stone TW, editor. Adenosine in the nervous system. London: Academic Press. p 41-76.
23. 3H]CGS 21680. Eur J Pharmacol 168:243-246.
24. Kalivas PW, Churchill L, Klitenick MA. 1993. GABA and enkephalin projection from the nucleus accumbens and ventral pallidum to the ventral tegmental area. Neuroscience 57:1047-1060.
25. Kittner H, Krügel U, Hoffmann E, Illes P. 2000. Effects of intraaccumbens injection of 2-methylthio ATP: A combined open field and electroencephalographic study in rats. Psychopharmacology (Berl) 150:123-131.
26. Kittner H, Krügel U, Illes P. 2001. The purinergic P2 receptor antagonist pyridoxalphosphate-6-azophenyl-2′4′-disulphonic acid prevents both the acute locomotor effects of amphetamine and the behavioural sensitization caused by repeated amphetamine injections in rats. Neuroscience 102:241-243.
27. Kiyatkin EA, Rebec GV. 1999. Modulation of striatal neuronal activity by glutamate and GABA: Iontophoresis in awake, unrestrained rats. Brain Res 822:88-106.
28. Koch M, Hauber W. 1998. Regulation of sensorimotor gating by interactions of dopamine and adenosine in the rat. Behav Pharmacol 9:23-29.
29. Kropf W, Kuschinsky K. 1991. Electroencephalographic correlates of the sedative effects of dopamine agonists presumably acting on autoreceptors. Neuropharmacology 30:953-960.
30. Krügel U, Kittner H, Illes P. 1999. Adenosine 5′-triphosphate-induced dopamine release in the rat nucleus accumbens in vivo. Neurosci Lett 265:49-52.
31. Krügel U, Kittner H, Illes P. 2001a. Mechanisms of adenosine 5′-triphosphate-induced dopamine release in the rat nucleus accumbens in vivo. Synapse 39:222-232.
32. Krügel U, Kittner H, Franke H, Illes P. 2001b. Stimulation of P2 receptors in the ventral tegmental area enhances dopaminergic mechanisms in vivo. Neuropharmacology 40:1083-1092.
33. Latini S, Pedata F. 2001. Adenosine in the central nervous system: Release mechanisms and extracellular concentrations. J Neurochem 79:463-484.
34. Lillrank SM, Lipska BK, Weinberger DR, Fredholm B, Fuxe K, Ferre S. 1999. Adenosine and dopamine receptor antagonist binding in the ventral and dorsal striatum: Lack of changes after a neonatal bilateral lesion of the ventral hippocampus. Neurochem Int 34:235-244.
35. Low MD. 1987. Psychology, psychophysiology, and the EEG. In: Niedermeyer E, Lopes da Silva F, editors. Electroencephalography. Baltimore, Munich: Urban & Schwarzenberg. p 567-578.
36. Machleidt W, Gutjahr L, Hinrichs H. 1994. Die Spektralmuster der Grundgefühle: Hunger, Angst, Aggression, Trauer und Freude. EEG-EMG 25:81-97.
37. 2A receptor modulation of electrically evoked endogenous GABA release from slices of rat globus pallidus. J Neurochem 60:2334-2337.
38. 1 purinergic receptor in the human brain: Striking neuronal localisation. J Comp Neurol 421:374-384.
39. Moore DJ, Chambers JK, Wahlin JP, Tan KB, Moore GB, Jenkins O, Emson PC, Murdock PR. 2001. Expression pattern of human P2Y receptor subtypes: A quantitative reverse transcription-polymerase chain reaction study. Biochim Biophys Acta 1521:107-119.
40. 1 purinergic receptor in neurons and glial cells of the central nervous system. Brain Res Mol Brain Res 78:50-58.
41. Okada M, Mizuno K, Kaneko S. 1996. Adenosine A1 and A2 receptors modulate extracellular dopamine levels in rat striatum. Neurosci Lett 212:53-56.
42. Patel DR, Young AM, Croucher MJ. 2001. Presynaptic alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate receptor-mediated stimulation of glutamate and GABA release in the rat striatum in vivo: A dual-label microdialysis study. Neuroscience 102:101-111.
43. Paxinos P, Watson C. 1986. The Rat Brain in Stereotaxic Coordinates. New York: Academic Press.
44. Pintor J, Porras A, Mora F, Miras-Portugal MT. 1995. Dopamine receptor blockade inhibits the amphetamine-induced release of diadenosine polyphosphates, diadenosine tetraphosphate and diadenosine pentaphosphate, from neostriatum of the conscious rat. J Neurochem 64:670-676.
45. 2A receptor stimulation enhances striatal extracellular glutamate levels in rats. Eur J Pharmacol 287:215-217.
46. Ralevic V, Burnstock G. 1998. Receptors for purines and pyrimidines. Pharmacol Rev 50:413-492.
47. Richardson PJ, Brown SJ. 1987. ATP release from affinity-purified rat cholinergic nerve terminals. J Neurochem 48:622-630.
48. Rosenberg PA, Li Y. 1995. Adenylyl cyclase activation underlies intracellular cyclic AMP accumulation, cyclic AMP transport, and extracellular adenosine accumulation evoked by beta-adrenergic receptor stimulation in mixed cultures of neurons and astrocytes derived from rat cerebral cortex. Brain Res 692:227-232.
49. Rosenberg PA, Knowles R, Knowles KP, Li Y. 1994. Beta-adrenergic receptor-mediated regulation of extracellular adenosine in cerebral cortex in culture. J Neurosci 14:2953-2965.
50. 2A receptor agonist. Eur J Neurosci 11:1587-1597.
51. Schaul N. 1998. The fundamental neural mechanisms of electroencephalography. Electroenceph Clin Neurophysiol 106:101-107.
52. 2 receptor (RDC8) is expressed by enkephalin but not by substance P neurons: An in situ hybridization histochemistry study. J Neurochem 57:1062-1067.
53. Segovia G, Del Arco A, Mora F. 1999. Effects of aging on the interaction between glutamate, dopamine, and GABA in striatum and nucleus accumbens of the awake rat. J Neurochem 73:2063-2072.
54. Silinsky EM. 1975. On the association between transmitter secretion and the release of adenine nucleotides from mammalian motor nerve terminals. J Physiol 247:145-162.
55. Stumpf G, Gogolak G. 1987. EEG and neuropharmacology - An experimental approach. In: Niedermeyer E, Lopes da Silva F, editors. Electroencephalography. Baltimore, Munich: Urban & Schwarzenberg. p 553-565.
56. Taber MT, Baker GB, Fibiger HC. 1996. Glutamate receptor agonists decrease extracellular dopamine in the rat nucleus accumbens in vivo. Synapse 24:165-172.
57. White TDHK. 1991. Release of adenosine and ATP from nervous tissue. In: Stone TW, editor. Adenosine in the Nervous System. London: Academic Press. p 174-195.
58. Wise RA, Bozarth MA. 1987. A psychomotor stimulant theory of addiction. Psychol Rev 94:469-492.
59. 1 receptor mediation. Neuropharmacology 28:21-25.
60. Zhang YX, Yamashita H, Ohshita T, Sawamoto N, Nakamura S. 1995. ATP increases extracellular dopamine level through stimulation of P2Y purinoceptors in the rat striatum. Brain Res 691:205-212.
61. Zimmermann H. 2000. Extracellular metabolism of ATP and other nucleotides. Naunyn Schmied Arch Pharmacol 362:299-309.